Skip to main content Accessibility help
×
Hostname: page-component-7b7567c8c-8tzhz Total loading time: 0 Render date: 2026-11-19T10:51:41.676Z Has data issue: false hasContentIssue false

Chapter 28 - Hyperbilirubinemia and Kernicterus

from Section 4 - Specific Conditions Associated with Fetal and Neonatal Brain Injury

Published online by Cambridge University Press:  31 July 2026

Sonia Lomeli Bonifacio
Affiliation:
Stanford University School of Medicine, California
Courtney J. Wusthoff
Affiliation:
University of California, Davis
Valerie Y. Chock
Affiliation:
Stanford University School of Medicine, California
Susan R. Hintz
Affiliation:
Stanford University School of Medicine, California
Maurice L. Druzin
Affiliation:
Emeritus of Stanford University School of Medicine, California
Alistair Jan Gunn
Affiliation:
University of Auckland
David K. Stevenson
Affiliation:
Stanford University School of Medicine, California
Get access

Summary

Kernicterus, historically defined as bilirubin deposition in the basal ganglia, has evolved into the broader terms chronic bilirubin encephalopathy and acute bilirubin encephalopathy, reflecting the spectrum of bilirubin-induced neurologic dysfunction (BIND). It arises from neonatal hyperbilirubinemia, where elevated bilirubin levels can lead to significant neurological damage. Pathophysiology of bilirubin neurotoxicity is complex, involving factors such as bilirubin production, conjugation capacity, and genetic predispositions. Unbound bilirubin levels correlate more closely with neurological outcomes than total serum bilirubin (TSB) levels. The risk of BIND is heightened in cases of severe hemolysis; TSB levels >20 mg/dL pose a significant threat to neonatal brain health. Recent trends indicate a resurgence of kernicterus, attributed to earlier hospital discharges and insufficient monitoring of bilirubin levels postdischarge. The 2022 American Academy of Pediatrics guidelines emphasize the importance of vigilant follow-up and intervention strategies, including phototherapy and exchange transfusion, to mitigate the risks associated with hyperbilirubinemia. Early identification and management of elevated bilirubin levels are crucial to prevent long-term consequences of bilirubin toxicity in neonates.

Information

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×